Trends in mortality from leukemia in Europe: An update to 2009 and a projection to 2012

International Journal of Cancer

Volumn 132, Issue 2, 2013, Pages 427-436

  Bertuccio, Paola ^a,b   Bosetti, Cristina ^a   Malvezzi, Matteo ^a,b   Levi, Fabio ^c   Chatenoud, Liliane ^a   Negri, Eva ^a   Vecchia, Carlo La ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Europe; leukemia; mortality; projections; trends

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER MORTALITY; EASTERN EUROPE; EUROPE; EUROPEAN UNION; FEMALE; HUMAN; INFANT; JAPAN; LEUKEMIA; MALE; MIDDLE AGED; PRIORITY JOURNAL; SEX RATIO; SOUTHERN EUROPE; UNITED STATES; WESTERN EUROPE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DEATH CERTIFICATES; EUROPE; FEMALE; HUMANS; INFANT; LEUKEMIA; MALE; MIDDLE AGED; MORTALITY; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 84869488566     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27624     Document Type: Article

References (36)

1. Kohler BA, Ward E, McCarthy BJ, et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 2011; 103: 714-36.
2. Qiu D, Katanoda K, Marugame T, et al. A Joinpoint regression analysis of long-term trends in cancer mortality in Japan (1958-2004). Int J Cancer 2009; 124: 443-8.
3. Levi F, Lucchini F, Negri E, et al. Trends in mortality from leukemia in subsequent age groups. Leukemia 2000; 14: 1980-5.
4. Wayne AS, Reaman GH, Helman LJ,. Progress in the curative treatment of childhood hematologic malignancies. J Natl Cancer Inst 2008; 100: 1271-3.
5. La Vecchia C, Bosetti C, Lucchini F, et al. Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol 2010; 21: 1323-60.
6. Bosetti C, Bertuccio P, Chatenoud L, et al. Childhood cancer mortality in Europe, 1970-2007. Eur J Cancer 2010; 46: 384-94.
7. World Health Organization Statistical Information System. WHO mortality database Available at: http://www3.who.int/whosis/menu.cfm. Last accessed on April 2011.
8. World Health Organization. International Classification of Disease, 8th revision edn. Geneva: World Health Organization, 1967.
9. World Health Organization. International Classification of Disease, 9th revision edn. Geneva: World Health Organization, 1977.
10. World Health Organization. International statistical classification of disease and related health problems, 10th revision edn. Geneva: World Health Organization, 1992.
11. Doll R, Smith PG,. Comparison between registries: age-standardized rates. vol. IV. IARC Sci Publ No. 42. In:, Waterhouse JAH, Muir CS, Shanmugaratnam K, Powell J, Peacham D, Whelan S, eds. Cancer incidence in five continents. Lyon: IARC, 1982. 671-5.
12. National Cancer Institute. Joinpoint Regression Program, version 3.5. Available at: http://srab.cancer.gov/joinpoint. Last accessed on April 2011.
13. Kim HJ, Fay MP, Feuer EJ, et al Permutation tests for joinpoint regression with applications to cancer rates. (Erratum in: Stat Med 2001; 20: 655). Stat Med 2000; 19: 335-51.
14. Clegg LX, Hankey BF, Tiwari R, et al. Estimating average annual per cent change in trend analysis. Stat Med 2009; 28: 3670-82.
15. Malvezzi M, Arfé A, Bertuccio P, et al. European cancer mortality predictions for the year 2011. Ann Oncol 2010; 22: 947-56.
16. European Commission. Eurostat population database. Available at: http://epp.eurostat.ec.europa.eu/portal/portal/page/portal/eurostat/home/. Last accessed on October 2010.
17. Klepin HD, Balducci L,. Acute myelogenous leukemia in older adults. Oncologist 2009; 14: 222-32.
18. Balducci L,. The geriatric cancer patient: equal benefit from equal treatment. Cancer Control 2001; 8: 1-25; quiz 7-8.
19. Levi F, Lucchini F, Negri E, et al. Changed trends of cancer mortality in the elderly. Ann Oncol 2001; 12: 1467-77.
20. Juliusson G, Karlsson K, Lazarevic VLj, et al. Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006. Cancer 2011; 117: 4238-46.
21. Boyle P, Levin B,. Leukaemias. In:, Boyle P, Levin B, eds. World Cancer Report 2008. World Health Organization. Lyon, France: International Agency for Research on Cancer, 2008. 474-80.
22. Fielding AK, Goldstone AH,. Allogeneic haematopoietic stem cell transplant in Philadelphia-positive acute lymphoblastic leukaemia. Bone Marrow Transplant 2008; 41: 447-53.
23. Pidala J, Djulbegovic B, Anasetti C, et al. Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission. Cochrane Database Syst Rev 2011: CD008818.
24. Popat U, Carrum G, Heslop HE,. Haemopoietic stem cell transplantation for acute lymphoblastic leukaemia. Cancer Treat Rev 2003; 29: 3-10.
25. Chan KW,. Acute lymphoblastic leukemia. Curr Probl Pediatr Adolesc Health Care 2002; 32: 40-9.
26. Estey EH,. How to manage high-risk acute myeloid leukemia. Leukemia 2011;26:861-9.
27. Jabbour E, Cortes JE, Giles FJ, et al. Current and emerging treatment options in chronic myeloid leukemia. Cancer 2007; 109: 2171-81.
28. Goldman JM, Melo JV,. Chronic myeloid leukemia-advances in biology and new approaches to treatment. N Engl J Med 2003; 349: 1451-64.
29. Kantarjian H, O'Brien S, Jabbour E, et al. Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience. Blood 2012; 119: 1981-7.
30. Breccia M, Tiribelli M, Alimena G,. Tyrosine kinase inhibitors for elderly chronic myeloid leukemia patients: a systematic review of efficacy and safety data. Crit Rev Oncol Hematol 2012. PMID: 22280914.
31. Abrisqueta P, Pereira A, Rozman C, et al. Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience. Blood 2009; 114: 2044-50.
32. Brenner H, Gondos A, Pulte D,. Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century. Blood 2008; 111: 4916-21.
33. van den Broek E, Kater P, van de Schans S, et al. Chronic lymphocytic leukaemia in the Netherlands: trends in incidence, treatment and survival, 1989-2008. Eur J Cancer 2012; 48: 889-95.
34. Auer RL, Gribben J, Cotter FE,. Emerging therapy for chronic lymphocytic leukaemia. Br J Haematol 2007; 139: 635-44.
35. Sant M, Allemani C, Santaquilani M, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009; 45: 931-91.
36. Chatenoud L, Bertuccio P, Bosetti C, et al. Childhood cancer mortality in America, Asia, and Oceania, 1970 through 2007. Cancer 2010; 116: 5063-74.